Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217085 · ClinicalTrials.gov registry record
Colorectal Polyp Resection Adequacy
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 288
- Enrollment target
NCT02217085: Completed study, sponsored by Rush University Medical Center.
NCT02217085 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02217085 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 288 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the best way to ensure that polyps are completely removed by evaluating the borders of the removed polyp. If a polyp is found that meets the size requirements for the study, the investigators will take extra biopsies of the margin to determine if there is any abnormal tissue or cancer at these borders.
Primary Outcome
Define the frequency of free margins versus margins that have dysplasia to the cautery site in snare polypectomy. A free margin is defined as uninvolved or normal mucosa extending to the cautery margin at the polypectomy stalk.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2014-05 |
| Est. Completion | 2022-06-30 |
What the finished NCT02217085 record still lists
NCT02217085 is an observational study that tracks outcomes without assigning an intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02217085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02217085 about?
NCT02217085 is a clinical study titled "Colorectal Polyp Resection Adequacy". The purpose of this study is to determine the best way to ensure that polyps are completely removed by evaluating the borders of the removed polyp. If a polyp is found that meets the size requirements for the study, the investigators will take extra biopsies of the margin to determine if there is an...
What is the current status of trial NCT02217085?
This trial is currently completed. The enrollment target is 288 participants. The study started on 2014-05. Estimated completion is 2022-06-30.
Who is sponsoring clinical trial NCT02217085?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia